COPD is mostly seen as a condition of older individuals, but it is present as well in younger adults [1]. “It is commonly assumed that COPD diagnosed earlier in life equates a milder form of the disease,” indicated Dr Alina J. Blazer (University of Toronto, ON, Canada). Dr Blazer and her fellow researchers strove to investigate the burden of disease in terms of healthcare usage and mortality of younger COPD patients, as currently there is little evidence on this group’s real-world clinical features.
Healthcare administrative data from 14 million Ontarians between 2006 and 2016 was screened and all younger adults with COPD (aged 35 to 55) as well as older ones (>65 years) were identified. Furthermore, corresponding rates of individuals without COPD of the same age groups were included. ”For comparison of relative differences, the data presented here has been normalised to the rate for older adults without COPD as one,” informed Dr Blazer. The findings that both older and younger COPD patients needed healthcare more often than individuals without COPD was not unexpected. “However, we were surprised to find how elevated the rates were among younger adults,” said Dr Blazer. Looking at all-cause hospitalisations, older adults with COPD had a ~2-fold increase compared with those without COPD (see Figure). However, in the younger group, the rate was more than 3 times higher for the COPD patients compared with individuals without COPD. Also, for emergency department visits and outpatient visits, the rates of the younger adults with COPD surpassed those of the COPD-free correspondents. Dr Blazer pointed out that the rate of emergency department visits approached that of older adults with COPD. Concerning mortality, the rate of older adults with COPD was 2.5 times higher than in their comparison group. Remarkably, younger adults with COPD had a 5-fold amplified mortality rate when compared to those without COPD.
Figure: Rates of hospitalisation, emergency department, and outpatient visits in the different groups [1]
“This study provided further evidence that so-called early COPD is not necessarily a benign entity and suggests that we should focus clinical efforts on identifying COPD in younger patients in the hope that earlier intervention may improve their current health, reduce resource utilisation, and prevent further disease progression,” concluded Dr Blazer.
- Blazer AJ. Excess Healthcare Utilization and Mortality in Younger Adults with COPD. Session C008: Innovations and updates in the study and management of COPD. ATS 2021 International Conference, 14-19 May.
Copyright ©2021 Medicom Medical Publishers
Posted on
Previous Article
« OSA: A risk factor for earlier cognitive decline Next Article
Men and women with COPD differ in many ways »
« OSA: A risk factor for earlier cognitive decline Next Article
Men and women with COPD differ in many ways »
Table of Contents: ATS 2021
Featured articles
Letter from the Editor
COVID-19: What Pulmonologists Need to Know
Antibody treatment for COVID-19: a combination is successful
Air pollution: an underestimated negative prognostic factor for COVID-19
Healthcare workers vulnerable to SARS-CoV-2 infections
Genetic risk variants responsible for COVID-19 predisposition
Asthma – An Update
“As-needed” inhaled corticosteroid therapy for mild asthma – what is the evidence?
IL-4/13 blocker successful in treatment of paediatric moderate-to-severe asthma
Benralizumab lives up to its phase 3 results in real-world findings
Tezepelumab – good success rates in various types of severe asthma
Sleep Disorders – An Underestimated Problem
OSA: A risk factor for earlier cognitive decline
Subgroup of patients with high heart rate response and coronary artery disease benefit from CPAP
Association between positive airway pressure treatment adherence and COVID-19 infection rates
COPD – What Is New
Possible aetiologies for COPD exacerbations – more evidence is needed
Does COPD plus COVID-19 equal higher mortality?
Biomarkers for acute exacerbations in COPD are required
Severe exacerbations: A key driver of all-cause mortality in COPD patients
Men and women with COPD differ in many ways
Younger adults with COPD at higher health risk than previously thought
Metabolic Dysregulation and Lung Disease
Obesity: A risk factor for new-onset asthma and worse asthma control
Metabolic dysfunction and lung disease: children are no small adults
Best of the Posters
Air pollution in winter linked to more hospital admissions in ILD patients
Tobacco biomarkers do not improve prediction of lung cancer risk
Vaping identified as risk factor for asthma
Related Articles
June 9, 2022
ATS 2022 Highlights Podcast
November 7, 2018
IPF introduction and Pentraxin-2
© 2024 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy
HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com